Ayurveda tech platform NirogStreet raises USD 2 million funding

The funds would also be used to strengthen the NirogStreet's reach and offerings to the Ayurveda doctors.

Published On 2020-10-17 03:30 GMT   |   Update On 2020-10-17 03:30 GMT
Advertisement

New Delhi - NirogStreet, a technology-led Ayurveda platform, on Thursday said it has raised USD 2 million (about Rs 14.6 crore) in funding led by Wavemaker Partners and Amand Ventures.

Existing investor Spiral Ventures has also participated in the pre-series A funding round, a statement said.

Also Read: Union Health Minister releases COVID-19 management protocol based on Ayurveda, yoga; Details

The startup will utilize the capital for deeper penetration, strengthen the technology platform and digitize the supply chain, it added.

Advertisement

The funds would also be used to strengthen the company's reach and offerings to the Ayurveda doctors, it said.

"Ayurveda has huge potential to bring India on the center stage of world healthcare. As a B2B2C technology-enabled and doctor-led platform, we are consistently streamlining the supply chain of Ayurvedic services and medicine, transforming it into a proper healthcare system by engaging and empowering Ayurveda doctors and clinics to create an experience that patients can trust," Ram N Kumar, founder of NirogStreet, said.

He added that Ayurveda is the natural choice of Indians as it is deeply rooted in the country's culture and civilization.

NirogStreet said it aims to expand its network of certified Ayurvedic clinics from 200 clinics to 5,000 clinics by 2022. It noted that 30 per cent of the doctors on its platform are from tier-I cities and the remaining are from tier-II and -III cities.

Also Read: All AYUSH systems need to be popularised: Madras HC pulls up Ministry

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News